Natacha Salomé Lima, A. Gustavo Martinez
JBRA Assist. Reprod. 2021; 25 (1):150-154
Received December 09, 2019
Accepted June 20, 2020
Abstract
CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debate and interdisciplinary discussion. This brings multiple challenges for both scientists and those who must regulate the use of these techniques.
